Journal
MICROBIAL PATHOGENESIS
Volume 115, Issue -, Pages 222-226Publisher
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.micpath.2017.12.054
Keywords
S. aureus; alpha-haemolysin; Anti-virulence; Epigallocatechin gallate
Categories
Funding
- National Natural Science Foundation of China [31602109]
- National Key Technology RD Program [2016YFD 05013]
Ask authors/readers for more resources
Staphylococcus aureus (S. aureus) is a common cause of hospital-acquired infection and has become an epidemic globally. Alpha-haemolysin (alpha-haemolysin), a pore-forming toxin, is one of the most important virulence factors secreted by most S. aureus strains. alpha-haemolysin monomers form a 232.4-kDa membrane-inserted heptamer by self-assembling to cause host cell lysis and death. Consequently, alpha-haemolysin plays a significant role in the pathogenesis of S. aureus, and it could be the target for the treatment of staphylococcal infection. In this study, epigallocatechin gallate (EGCg), a natural compound with little anti-S. aureus activity, was shown to reduce the haemolytic activity of alpha-haemolysin by inhibiting the self-assembly of the heptamer. When EGCg was added into a co-cultured system of human alveolar epithelial (A549) cells and bacterial suspension, alpha-haemolysin-induced cell injury was significantly attenuated. These results indicate that EGCg could effectively reduce the cytotoxicity of the toxin by interacting with alpha-haemolysin. This study provides the basis for the development of anti-virulence drugs for the treatment of S. aureus infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available